A phase 1b study of once-weekly carfilzomib combined with lenalidomide and dexamethasone in patients with newly diagnosed multiple myeloma.
Am J Hematol
; 96(2): 226-233, 2021 02 01.
Article
in En
| MEDLINE
| ID: mdl-33125764
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Antineoplastic Combined Chemotherapy Protocols
/
Multiple Myeloma
Type of study:
Clinical_trials
/
Diagnostic_studies
Language:
En
Journal:
Am J Hematol
Year:
2021
Document type:
Article
Affiliation country:
United States
Country of publication:
United States